These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20682587)

  • 1. Activation of cytokine-producing and antitumor activities of natural killer cells and macrophages by engagement of Toll-like and NOD-like receptors.
    Qiu F; Maniar A; Diaz MQ; Chapoval AI; Medvedev AE
    Innate Immun; 2011 Aug; 17(4):375-87. PubMed ID: 20682587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.
    Hart OM; Athie-Morales V; O'Connor GM; Gardiner CM
    J Immunol; 2005 Aug; 175(3):1636-42. PubMed ID: 16034103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity.
    Lauzon NM; Mian F; MacKenzie R; Ashkar AA
    Cell Immunol; 2006 Jun; 241(2):102-12. PubMed ID: 17049504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56
    Veneziani I; Alicata C; Pelosi A; Landolina N; Ricci B; D'Oria V; Fagotti A; Scambia G; Moretta L; Maggi E
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35091452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of TLR3 and TLR7 activation in uterine NK cells from non-obese diabetic (NOD) mice.
    Lin Y; Ren L; Wang W; Di J; Zeng S; Saito S
    J Reprod Immunol; 2009 Oct; 82(1):12-23. PubMed ID: 19560213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells.
    Tada H; Aiba S; Shibata K; Ohteki T; Takada H
    Infect Immun; 2005 Dec; 73(12):7967-76. PubMed ID: 16299289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR Agonists Modify NK Cell Activation and Increase Its Cytotoxicity in Acute Lymphoblastic Leukemia.
    Gallardo-Zapata J; Pérez-Figueroa E; Olivar-López V; Medina-Sansón A; Jiménez-Hernández E; Ortega E; Maldonado-Bernal C
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA.
    Schmidt KN; Leung B; Kwong M; Zarember KA; Satyal S; Navas TA; Wang F; Godowski PJ
    J Immunol; 2004 Jan; 172(1):138-43. PubMed ID: 14688319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells.
    Sivori S; Falco M; Della Chiesa M; Carlomagno S; Vitale M; Moretta L; Moretta A
    Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10116-21. PubMed ID: 15218108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
    Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
    Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nucleotide-binding oligomerization domain 1 during cytokine production by macrophages in response to Mycobacterium tuberculosis infection.
    Lee JY; Hwang EH; Kim DJ; Oh SM; Lee KB; Shin SJ; Park JH
    Immunobiology; 2016 Jan; 221(1):70-5. PubMed ID: 26255090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity.
    Dietsch GN; Lu H; Yang Y; Morishima C; Chow LQ; Disis ML; Hershberg RM
    PLoS One; 2016; 11(2):e0148764. PubMed ID: 26928328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines.
    Uehara A; Fujimoto Y; Fukase K; Takada H
    Mol Immunol; 2007 May; 44(12):3100-11. PubMed ID: 17403538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.
    Sommariva M; Le Noci V; Storti C; Bianchi F; Tagliabue E; Balsari A; Sfondrini L
    Cell Immunol; 2017 Mar; 313():52-58. PubMed ID: 28089340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to proteinase 3 prime human monocytic cells via protease-activated receptor-2 and NF-kappaB for Toll-like receptor- and NOD-dependent activation.
    Uehara A; Iwashiro A; Sato T; Yokota S; Takada H
    Mol Immunol; 2007 Jul; 44(14):3552-62. PubMed ID: 17452051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INAM plays a critical role in IFN-γ production by NK cells interacting with polyinosinic-polycytidylic acid-stimulated accessory cells.
    Kasamatsu J; Azuma M; Oshiumi H; Morioka Y; Okabe M; Ebihara T; Matsumoto M; Seya T
    J Immunol; 2014 Nov; 193(10):5199-207. PubMed ID: 25320282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.
    Kvarnhammar AM; Petterson T; Cardell LO
    Immunology; 2011 Nov; 134(3):314-25. PubMed ID: 21978001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
    Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
    Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.